CARB-X
 CARB-X     | |
|---|---|
| Headquarters | Boston University, Massachusetts, USA |
| Interests | Antimicrobial resistance, antibiotics, antimicrobials |
| Sponsored by | BARDA, Bill & Melinda Gates Foundation, National Institute of Allergy and Infectious Diseases, Wellcome Trust |
Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global nonprofit partnership focused on supporting the development of new antibacterial products.
Activities
"The CARB-X initiative plays an important role in BARDA's goal to catalyze the early stage development pipeline and enhance our national health security preparedness. CARB-X allows BARDA to tap into a partnership of co-funders, accelerators, and innovators who are pushing critical novel antimicrobials from discovery to the market to address the public health and national security concerns of antibiotic resistant bacteria."[1]
Board members
The Joint Oversight Board and Advisory Board members are secret.[2]
Finances
Many of the usual suspects.[3]
Known member
1 of the 74 of the members already have pages here:
| Member | Description |
|---|---|
| Debra Goff | US doctor |
Sponsors
| Event | Description |
|---|---|
| BARDA | Responsible for bioterrorism "medical countermeasures" (i.e. the actual biological weapons, like "vaccines") |
| Bill & Melinda Gates Foundation | Very influential and rich foundation established to take leadership of global health. |
| National Institute of Allergy and Infectious Diseases | |
| Wellcome Trust | 4th wealthiest charitable foundation in the world |
